Allan-Herndon-Dudley syndrome is caused by mutations in the gene coding for a thyroid hormone transporter, preventing thyroid ...
The European Medicines Agency (EMA) has recommended extending the use of Ofev (nintedanib) to include treating progressive ...
A cardiologist is suing his hospital for allegedly firing him for reporting patient safety concerns about another ...
Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...
The initiation of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs), particularly rituximab ...
Utah recently became the seventh state to allow trained psychologists to prescribe psychotropics, sparking hope among ...
Results of the INSEMA trial indicated that it’s safe to omit axillary sentinel lymph node biopsy in patients with clinically ...
Outside experts say, however, that the choice of control group in the trial may limit the relevance to clinical practice.
Mounting research suggested angiotensin receptor blockers reduce the risk for epilepsy in patents with hypertension and ...
The EMA’s Committee for Medicinal Products for Human Use (CHMP) determined that expected clinical benefits of seladelpar include delayed development of liver fibrosis and cirrhosis, potentially ...
LOS ANGELES — The median cost of brand-name anti-seizure medications (ASMs) in the United States almost doubled from 2013 to ...
A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback